Search Results - "Almontashiri, Naif"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Plasma PCSK9 levels are elevated with acute myocardial infarction in two independent retrospective angiographic studies by Almontashiri, Naif A M, Vilmundarson, Ragnar O, Ghasemzadeh, Nima, Dandona, Sonny, Roberts, Robert, Quyyumi, Arshed A, Chen, Hsiao-Huei, Stewart, Alexandre F R

    Published in PloS one (02-09-2014)
    “…Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a circulating protein that promotes degradation of the low density lipoprotein (LDL) receptor…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Clinical Validation of Targeted and Untargeted Metabolomics Testing for Genetic Disorders: A 3 Year Comparative Study by Almontashiri, Naif A. M., Zha, Li, Young, Kim, Law, Terence, Kellogg, Mark D., Bodamer, Olaf A., Peake, Roy W. A.

    Published in Scientific reports (10-06-2020)
    “…Global untargeted metabolomics (GUM) has entered clinical diagnostics for genetic disorders. We compared the clinical utility of GUM with traditional targeted…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity by Shuaib, Muhammad, Adroub, Sabir, Mourier, Tobias, Mfarrej, Sara, Zhang, Huoming, Esau, Luke, Alsomali, Afrah, Alofi, Fadwa S, Ahmad, Adeel Nazir, Shamsan, Abbas, Khogeer, Asim, Hashem, Anwar M, Almontashiri, Naif A M, Hala, Sharif, Pain, Arnab

    Published in Genome medicine (21-07-2023)
    “…The excessive inflammatory responses provoked by SARS-CoV-2 infection are critical factors affecting the severity and mortality of COVID-19. Previous work…”
    Get full text
    Journal Article
  12. 12

    Clinical characterization and further confirmation of the autosomal recessive SLC12A2 disease by Bilal Shamsi, Monis, Saleh, Mohamed, Almuntashri, Makki, Alharby, Essa, Samman, Manar, Peake, Roy W A, Al-Fadhli, Fatima M, Alasmari, Ali, Faqeih, Eissa A, Almontashiri, Naif A M

    Published in Journal of human genetics (01-07-2021)
    “…Heterozygous pathogenic variants in SLC12A2 are reported in patients with nonsyndromic hearing loss. Recently, homozygous loss-of-function variants have been…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    ME2 Deficiency Is Associated With Recessive Neurodevelopmental Disorder by Almontashiri, Naif A M, Alharby, Essa, Saleh, Mohammed, Abu-Farha, Mohamed, Alasmari, Ali, Gebbia, Marinella, Hiesl, Charlotte, Peake, Roy W A, Amr, Sami Samir, Boles, Eckhard, Roth, Frederick P, Abubaker, Jehad

    Published in Clinical genetics (14-10-2024)
    “…Malate is an important dicarboxylic acid produced from fumarate in the tricarboxylic acid cycle. Deficiencies of fumarate hydrolase (FH) and malate…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Recurrent variants in OTOF are significant contributors to prelingual nonsydromic hearing loss in Saudi patients by Almontashiri, Naif A M, Alswaid, Abdulrahman, Oza, Andrea, Al-Mazrou, Khalid A, Elrehim, Omnia, Tayoun, Ahmad Abou, Rehm, Heidi L, Amr, Sami S

    Published in Genetics in medicine (01-05-2018)
    “…Purpose Hearing loss is more prevalent in the Saudi Arabian population than in other populations; however, the full range of genetic etiologies in this…”
    Get full text
    Journal Article
  19. 19

    Interferon-γ Activates Expression of p15 and p16 Regardless of 9p21.3 Coronary Artery Disease Risk Genotype by Almontashiri, Naif A.M., MSc, Fan, Meng, PhD, Cheng, Brian L.M., BSc, Chen, Hsiao-Huei, PhD, Roberts, Robert, MD, Stewart, Alexandre F.R., PhD

    “…Objectives Because post-transcriptional mechanisms modulate levels of p16 (encoded by CDKN2A ) and p15 (encoded by CDKN2B ), we tested whether interferon-γ…”
    Get full text
    Journal Article
  20. 20